Company News 27 Jun 2022 Striate+â„¢ global exclusive license and manufacturing agreement with BioHorizons Orthocell (ASX:OCC) has signed a global exclusive license and manufacturing agreement for its FDA-cleared dental product, Striate+â„¢, with BioHorizons Implant… Orthocell
